Selected article for: "clinical pathway and RT facility"
Author: Conghua Xie; Xiaoyong Wang; Hui Liu; Zhirong Bao; Jing Yu; Yahua Zhong; Melvin LK Chua
Title: Infection Control of 2019 Novel Corona Virus Disease (COVID-19) in Cancer Patients undergoing Radiotherapy in Wuhan
  • Document date: 2020_3_24
    • ID: njo93g3h_4
    Snippet: We reviewed all patients who were treated at the Zhongnan Hospital of Wuhan University (ZHWU) from Jan 20 to Mar 6, 2020 . This preceded the city lock-down date of Jan 23, 2020. Infection control measures were implemented, which included a clinical pathway for managing suspect COVID-19 cases, on-site screening, modifications to the RT facility, and protection of healthcare workers. Primary end-point was infection rate among patients and healthcar.....
    Document: We reviewed all patients who were treated at the Zhongnan Hospital of Wuhan University (ZHWU) from Jan 20 to Mar 6, 2020 . This preceded the city lock-down date of Jan 23, 2020. Infection control measures were implemented, which included a clinical pathway for managing suspect COVID-19 cases, on-site screening, modifications to the RT facility, and protection of healthcare workers. Primary end-point was infection rate among patients and healthcare staff. Diagnosis of COVID-19 was based on the 5 th edition criteria. during the study period. No healthcare worker was infected.

    Search related documents:
    Co phrase search for related documents
    • infection control and primary end point: 1, 2
    • infection control and RT facility: 1, 2, 3, 4, 5, 6
    • infection rate and lock date: 1
    • infection rate and primary end point: 1, 2, 3
    • infection rate and RT facility: 1
    • infection rate and site screening: 1, 2
    • infection rate and study period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • infection rate and suspect case: 1
    • lock date and primary end point: 1
    • lock date and RT facility: 1
    • lock date and site screening: 1
    • lock date and study period: 1, 2
    • primary end point and RT facility: 1
    • primary end point and site screening: 1
    • primary end point and study period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • RT facility and site screening: 1, 2
    • RT facility and study period: 1
    • site screening and study period: 1, 2
    • study period and suspect case: 1, 2